Yuhan Corporation ranked first in consumer interest among pharmaceutical companies in March 2026 with 9,376 online postings, followed by Hanmi Pharm and Dong-A Pharmaceutical.
GC Pharma applies for Hunterase ICV approval in Peru
GC Pharma applied for approval of Hunterase ICV, a Hunter syndrome treatment, in Peru on January 27. The Peruvian drug regulator is reviewing the application.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.